U.S. Government Health Plans Spent Over $1 Billion On EpiPens Over Past 5 Years
Category: POLITICS
Now the company behind the emergency allergic reaction treatment is under additional scrutiny.
By By Bill Berkrot, Reuters, 2016-10-06